Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionTrinity Legacy Partners, LLC
Latest Disclosed Ownership17,253 shares
Latest Disclosed Value $ 6,054,975
Trinity Legacy Partners, LLC reports 0.42% decrease in ownership of AMGN / Amgen Inc.

On April 16, 2026 - Trinity Legacy Partners, LLC filed a 13F-HR form disclosing ownership of 17,253 shares of Amgen Inc. (MX:AMGN) valued at $6,054,975 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 17,326 shares of Amgen Inc.. This represents a change in shares of -0.42% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AMGEN COM 031162100 17,253 -73 -0.42 6,055 6.77 1.3110
2026-01-26 2025-12-31 13F AMGEN COM 031162100 17,326 273 1.60 5,671 11.42 1.3008
2025-11-04 2025-09-30 13F AMGEN COM 031162100 17,053 743 4.56 5,089 4.37 1.1713
2025-07-21 2025-06-30 13F AMGEN COM 031162100 16,310 178 1.10 4,877 11.78 1.1848
2025-05-14 2025-03-31 13F AMGEN COM 031162100 16,132 612 3.94 4,363 7.84 1.1039
2025-02-03 2024-12-31 13F AMGEN COM 031162100 15,520 138 0.90 4,045 -18.99 1.0422
2024-10-31 2024-09-30 13F AMGEN COM 031162100 15,382 239 1.58 4,993 5.54 1.2830
2024-08-14 2024-06-30 13F AMGEN COM 031162100 15,143 87 0.58 4,731 10.54 1.3456
2024-04-24 2024-03-31 13F AMGEN COM 031162100 15,056 2,289 17.93 4,281 16.40 1.2538
2024-02-14 2023-12-31 13F AMGEN COM 031162100 12,767 36 0.28 3,677 7.48 1.1587
2023-10-11 2023-09-30 13F AMGEN COM 031162100 12,731 12,731 3,421 1.1818
2022-10-12 2022-09-30 13F AMGEN COM 031162100 0 -1,143 -100.00 0 -100.00
2022-07-12 2022-06-30 13F AMGEN COM 031162100 1,143 0 0.00 283 2.54 0.1100
2022-04-13 2022-03-31 13F AMGEN COM 031162100 1,143 0 0.00 276 7.39 0.0932
2022-01-13 2021-12-31 13F AMGEN COM 031162100 1,143 1,143 257 0.0871
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.